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Summary
Objective: To determine whether chondrocyte apoptosis occurs during the progression of osteoarthritis (OA) in the STR/ort mouse model
of OA.
Methods: Serial cryostat sections were cut (10 microns) through the knee joint of young and old male STR/ort mice and graded for the
severity of OA lesions. Age- and sex-matched CBA mice were used as controls. Apoptotic chondrocytes were detected using the TUNEL
assay. Ultrastructural changes were examined using electron microscopy (EM). Expression of biochemical markers associated with
apoptosis (bax, bcl-2 and caspases-3, -8 & -9) was investigated using immunohistochemistry.
Results: TUNEL assays on histological sections of STR/ort knee joints showed that the number of TUNEL-positive chondrocytes in the tibial
medial articular cartilage correlated with the severity of the OA damage. These cells were located close to the lesional area. Only very
occasional TUNEL positive chondrocytes were detected in either morphologically normal STR/ort cartilage or in control CBA cartilage.
Ultrastructural analysis of chondrocytes neighboring focal osteoarthritic lesions in STR/ort tibial cartilage revealed an abundance of abnormal
cells exhibiting numerous morphological changes. These resembled, but in some cases differed, from changes reported in classical
apoptosis. The changes include abnormal distribution of chromatin, cell shrinkage, membrane blebbing and deposition of cell remnants
(apoptotic bodies) in the lacuna space. Despite the TUNEL and EM changes, immunohistochemistry failed to detect any changes in the ratio
of bax to bcl-2 in tibial chondrocytes of STR/ort mice. Both bcl-2 and bax levels decreased with age in morphologically normal STR/ort and
control CBA cartilage. None of the caspases tested for was detected in tibial chondrocytes of either strain.
Conclusion: Chondrocyte cell death is correlated with the progression of OA in STR/ort mice and has many of the morphological
characteristics of classical apoptosis. Absence of changes in bax to bcl-2 ratio in STR/ort chondrocytes indicate that the mitochondrial
pathway of apoptosis is unlikely to be involved. Failure to detect caspases could be due to low levels of enzyme expression, expression
within a very brief time period, or to a caspase-independent mechanism of cell death.
© 2003 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Introduction
During apoptosis, or ‘programed cell death’, the cell or-
chestrates its own breakdown and clearing without tissue
damage and inflammation1–5. The ability of a cell to initiate
this process is dependent on it receiving apoptotic signals
or, as some have reported, failing to receive cell survival
signals5. With the exception of transformed cells, all
cells are programed to die, but the timing is dependent on
the overall status of the cell. Under normal situations,
apoptosis is a tightly regulated process. However, during
pathological situations aberrant apoptosis often occurs. For
example, insufficient levels of apoptosis accompanies the
development of some cancers5, whereas excessive levels
of apoptosis play a part in several neurodegenerative and
musculoskeletal diseases6–9. Apoptosis of chondrocytes
has been reported in osteoarthritis (OA) in both in vivo and
in vitro systems9,10.
The STR/ort mouse develops spontaneous OA of the
medial tibial plateau between 12–20 weeks and is a useful
model in which to study the pathogenesis of the disease.
The histopathological lesions are progressive and closely
resemble those of human knee osteoarthritis11–14. Lesions
are reported to occur most commonly in the male STR/ort
mouse15, but more recent evidence showed that they
develop in either sex independently of gonadectomy16.
Cartilage breakdown is effected by aggrecanases, colla-
genases and other matrix metalloproteinases (MMPs)16,17.
mRNA levels of collagenase 3 (MMP-13) are markedly
increased in STR/ort tibial chondrocytes18 and recently we
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detected much increased levels of the enzyme in cartilage
extracts from mice up to about 20 weeks of age19 using a
fluorokine assay, compared to levels in extracts from con-
trol CBA or DBA strain mice. However, in situ hybridization
studies indicate that the mRNA level of MMPs is decreased
in chondrocytes located in the vicinity of advanced histo-
pathological lesions of STR/ort tibial cartilage18. Likewise,
expression of cytokines and extracellular matrix proteins
is frequently decreased in such cells20,21. These observa-
tions suggest that these chondrocytes are either metaboli-
cally dormant or dead. In this paper we report experiments
to test whether chondrocyte apoptosis occurs in STR/ort
tibial chondrocytes and show that it does so with increas-
ing frequency with progression of the histopathological
lesions.
Materials and methods
PREPARATION AND SECTIONING OF KNEE JOINTS FOR LIGHT
MICROSCOPY
STR/ort mice were from the Imperial College London
colony. CBA strain mice, which show no evidence of
histological OA lesions at the ages studied16–21, were used
as controls and were purchased commercially (Charles
River Laboratories, Margate, Kent, U.K.). Male mice of both
strains were sacrificed between 6–40 weeks of age. Mice
were killed by cervical dislocation. An incision was made in
the ankle region and the skin dissected away. The patella
was marked with a permanent marker (to assist orientation
for sectioning) before dissecting out the joint. The dissected
tissues were then placed in 5% polyvinyl alcohol (PVA)
solution (Sigma, Poole, Dorset, U.K.) and chilled to −70°C
in n-hexane, cooled by industrial methylated spirits and
solid carbon dioxide. They were then stored at −80°C until
sectioning. For sectioning, the frozen undecalcified knee
joints were mounted on metal chucks with the patella
facing up. Sectioning of the whole joint was carried out in
the anterior to posterior direction. Serial 10 µm sections
were cut and flash-dried onto chrome-alum coated micro-
scope slides. Each unstained serial section was examined
by light microscopy and a preliminary grade assigned for
the severity of any OA lesions present, using a scale of
0 (normal cartilage) to 6 (>80% loss of medial tibial
plateau cartilage), as described previously20. Grades were
checked and revised if necessary when sections were
used for the TUNEL assay or for immunohistochemical
staining (see below) when accurate grading can be carried
out with confidence. Sections were stored at –80°C until
required.
TUNEL
DNA fragmentation in chondrocytes was detected by the
terminal deoxynucleotidyl transferase-mediated dUTP nick
end labeling (TUNEL) method using a commercial kit, the
Apoalert DNA Fragmentation Assay (Clontech Laboratories
Inc., Palo Alta, CA, U.S.A.). This method is accepted
generally as detecting apoptotic cells. It was carried out
using the manufacturer’s protocol but with an alternative
labeling solution. Briefly, frozen cryostat sections were
fixed with 4% paraformaldehyde/PBS. The fixed sections
were subjected to brief proteinase K digestion (10 µg/ml)
(5 min, room temperature) before being fixed, washed
and incubated with equilibrium buffer for 30 min. 50 µl
of reaction mixture [containing 45 µl Labelling Solution
(Roche Ltd., Lewes, East Sussex, U.K.), 4 µl Equilibrium
Buffer, 1 µl Transferase Enzyme] was then added, and the
sections incubated for 60 min at 37°C. The sections were
further treated with 1×SSC solution before mounting with
a fluorescence mounting medium containing propidium
iodide to counterstain the nuclei red (Vector Laboratories
Inc., Peterborough, U.K.). Sections were examined with an
Olympus Provis fluorescence microscope. Positive control
sections were generated by treating them with DNase 1
(0.1 µg/ml, 1.1×10−5 U/mg; Amersham Biosciences U.K.
Ltd., Chalfont St. Giles, U.K.) for 15 min at room tempera-
ture, after which they were processed, as above.
Normal nuclei appear red whilst apoptotic nuclei appear
yellow-green. To quantitate the number of apoptotic
chondrocytes in tibial cartilage, sections were chosen from
joints having well-defined histopathological lesions of
specific grades 0–6 (see above). For each joint, the section
showing the maximum change for a specific grade of lesion
was imaged, the area of the medial tibial articular cartilage
measured using NIH image software and the number of
apoptotic cells within the area counted.
ELECTRON MICROSCOPY
Excess muscle and tissue was dissected away from the
joint prior to fixing in 2% glutaraldehyde buffered with 0.1 M
sodium cacodylate buffer (pH 7.4), for 7 days. Following
initial fixation, the samples were transferred into 0.1 M
sodium cacodylate buffer containing 0.1 M EDTA. To en-
sure full decalcification, they were then left at 4°C for 3
weeks. Following decalcification, the samples were further
trimmed, washed and then post fixed for 1 h in 1% osmo-
nium tetroxide, buffered with sodium cacodylate buffer.
Post-fixed samples were then dehydrated in a graded
alcohol series prior to embedding in Spurr’s resin. Thin
(2 µm) and ultrathin (90 nm) sections were cut using an
ultramicrotome. Thin sections were stained with toluidine
blue and a suitable area was selected. The selected area
ultrathin sections were stained with urynyl acetate and
lead citrate22 and viewed using a Phillips CM12 electron
microscope.
IMMUNOHISTOCHEMISTRY
The following antibodies were purchased; Rabbit anti-
mouse bcl-2 (cat. no. 1516E; PharMingen, San Diego,
CA, U.S.A.), bax (Ab-I) and bax blocking peptide (cat.
nos. PC66 and PP01-PP62 respectively; Calbiochem,
Cambridge, MA, U.S.A.). All three caspase antibodies
(Goat anti-CPP32p11, 1:400, cat no. RDI-CPP32NabG;
Goat anti-MCH5p20, 1:200, cat. no. RDI-MCH52Nabg;
Rabbit anti-MCHp10/caspase-9, 1:100, cat no. RDI-
MCH6CabR) and a blocking peptide to the caspase-8
antibody (cat. no. RDI-MCH520N-P) were purchased from
Research Diagnostics Inc.(Flanders, NJ, U.S.A.). The
caspases were detected by immunofluorescence using
FITC-labeled rabbit anti-goat IgG (cat. no. F0250) and
FITC-labeled swine anti-rabbit IgG (cat. no. F0205). These
were purchased from DAKO (Ely, Cambridgeshire, U.K.).
Immunohistological staining of frozen knee joint sections
was carried out using the Vectastain ABC kit (Vector
Laboratories, Peterborough, U.K.) with a variation to the
manufacturers protocol. Sections were allowed to warm to
room temperature prior to fixing with acetone (10 min at
4°C). Sections were washed with PBS and then incubated
with the appropriate primary antibody (diluted in PBST/5%
132 D. Mistry et al.: Chondrocyte death during murine osteoarthritis
serum) at 4°C overnight. Control sections were treated in
the same way except the primary antibody was omitted.
Following incubation, the slides were washed and then
treated with the secondary antibody (provided with the
Vectastain ABC kit). The rest of the protocol was in accord-
ance with the manufacturer’s manual.
For immunofluorescence staining of caspases, sections
were incubated with the appropriate FITC-labeled
secondary antibody for 90 min at 37°C. The sections were
subsequently washed and mounted using a fluorescence
mounting medium containing propidium iodide (Vector
Laboratories Inc., Peterborough, U.K.).
Results
TUNEL ASSAY
The TUNEL assay is used to identify cells which possess
nicked DNA ends, one indicator of activation of the apop-
totic pathway. Knee joint sections of STR/ort male mice
ages 6–30 weeks of age- and sex-matched CBA mice were
tested for the presence of TUNEL-positive cells. Young
(6 week) mice of both strains had morphologically normal
tibial articular cartilage with a smooth surface and almost
all chondrocyte nuclei stained red with propidium iodide,
indicating the presence of intact DNA (Fig. 1 A, B). Very
few TUNEL positive cells, which stain yellow-green, were
detected in these cartilages, and when present they were
randomly distributed throughout the full depth of the carti-
lage. Occasional TUNEL positive cells were also detected
in the calcified cartilage of these young animals. The
articular cartilage of older CBA mice (e.g. 30 week) was
also morphologically normal and contained few TUNEL
positive cells (Fig. 1C). It was indistinguishable from the
cartilage of young mice in this respect. However, there
were increased numbers of TUNEL-positive cells in the
calcified cartilage of older CBA mice (Fig. 1C). In control
experiments, predigestion of the section with DNase I
resulted in many chondrocytes in morphologically normal
articular cartilage showing a TUNEL-positive signal (data
not shown). Non-chondrocytic cells in other parts of the
section also gave a positive TUNEL signal. Thus the
TUNEL reaction detects cells with nicked DNA if they are
present in the joint tissues.
As STR/ort mice became older they developed osteo-
arthritic lesions in the medial tibial cartilage, as expected,
whilst the lateral cartilage was almost always spared, in
agreement with previous findings14. There were numerous
TUNEL-positive chondrocytes in areas of the medial carti-
lage where lesions occurred (Fig. 1D), but few in the areas
of the medial tibial cartilage of STR/ort mice where the
tissue had a morphologically normal appearance. Likewise,
morphologically normal lateral tibial cartilage contained
only very occasional TUNEL-positive cells in older STR/ort
mice (Fig. 1E). The number and appearance of TUNEL-
positive cells in either lesional or morphologically normal
Fig. 1. TUNEL-positive chondrocytes in CBA and STR/ort mouse tibial cartilage as detected by an in situ TUNEL assay. Normal chondrocytes
stained orange-red. Very few TUNEL-positive cells (yellow-green) are detected in the hyaline cartilage of either 6-week-old CBA (A),
6-week-old STR/ort (B) or 30- week-old CBA (C) mice. As STR/ort mice age and develop OA lesions in the medial tibial cartilage, the number
of TUNEL-positive cells increase in the region of the lesion (>), as shown for a 12-week-old mouse, OA grade 2 (D). The corresponding
lateral plateaux shows only basal levels of TUNEL-positive cells, at all ages (E). STR/ort mice with more advanced OA lesions in the
medial plateau have even higher numbers of TUNEL-positive cells in the region of the lesion, as shown by a 21-week-old male mouse,
OA grade 4 (>) (F). ac, articular cartilage; b, bone; cc, calcified cartilage; m, meniscus. Original magnifications, ×38.
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cartilage was unaffected by predigestion of the section with
chondroitinase ABC indicating that the TUNEL-reaction
was not masked by the presence of adjacent matrix
chondroitin sulfate (data not shown).
The number of TUNEL-positive chondrocytes in lesional
areas of the STR/ort medial cartilage increased with in-
creasing severity of the OA lesion (Fig. 1F). A study of 38
knee joints from STR/ort male mice aged 20–40 weeks with
varying grades of OA lesion (grade 0–6) was carried out to
assess this, as described in the Methods section. The
results confirmed that there is a definite increase in
TUNEL-positive chondrocytes in cartilage adjacent to
lesions with increasing grade of lesion (correlational
coefficient r=0.87) (Fig. 2 ).
ULTRASTRUCTURAL STUDIES OF STR/ORT MOUSE ARTICULAR
CARTILAGE
The TUNEL assay may fail to distinguish between cell
death by apoptosis or by necrosis. Thus additional morpho-
logical evidence of chondrocyte apoptosis was sought. EM
studies were carried out to identify apoptotic cells in dam-
aged STR/ort cartilage. Initial light microscopy of thin joint
sections revealed several differences between morphologi-
cally normal and damaged STR/ort medial tibial cartilage.
The normal cartilage appeared relatively thick. The mid and
deep zoons stained intensely with toluidine blue, whilst the
articular surface showed evidence of loss of staining (Fig. 3
A). The underlying bone showed extensive vascularization
and bone marrow pools containing numerous bone
marrow-derived cells. In contrast in areas with histopatho-
logical OA lesions, the cartilage was thinner, stained only
poorly with toluidine blue throughout the full depth, and
was fibrillated (Fig. 3B). The underlying bone was highly
sclerotic with increased deposition of mineralized material
in previously bone marrow-filled spaces.
Ultrastructural investigations showed marked differences
between chondrocytes located in morphologically normal
parts of the STR/ort tibial plateau cartilage and those
adjacent to OA lesions. The normal chondrocytes had a
prominent nucleus surrounded by a well-defined cytoplasm
containing numerous intact organelles (Fig. 4 A). The
chromatin was electron dense and exhibited an organised
distribution within the nucleus. The cell membrane was
intact and numerous cytoplasmic processes extended from
it towards the lacunar rim. There was only a small area of
lacuna space between the cell membrane and the rim and
this had a relatively transparent appearance with a net-like
organisation within it. In contrast, chondrocytes adjacent to
osteoarthritic lesions had a highly abnormal appearance
(Fig. 4B–E). These chondrocytes were smaller than normal
chondrocytes (Fig. 4B–D) and in some cases, when
located in regions of advanced lesions, were highly frag-
mented (Fig. 4B). In areas of less advanced lesions they
appeared more intact but occupied a much smaller amount
of lacuna space (Fig. 4C, D). Although the nucleus in such
cells was still readily distinguished from the cytoplasm, the
chromatin was disorganised. The cell membrane, although
intact, was irregular and showed multiple membrane blebs
(Fig. 4C). These are characteristics of apoptotic cells.
Cytoplasmic remnants could be seen budding off from the
cytoplasm (Fig. 4D, E) and probably represent apoptotic
bodies. The lacuna space contained many cell membrane
bound bodies of varying sizes (Fig. 4C, D). Interestingly,
when osteoarthritic lesions were present (e.g. erosions,
fibrillations), abnormal chondrocytes such as those shown
in Fig. 4B–D were detected throughout the full depth of the
hyaline cartilage to its junction with the calcified cartilage,
even when the lesion was not full depth. No normal
chondrocytes were detected adjacent to fibrillations.
BIOCHEMICAL MARKERS OF APOPTOSIS
The expression of various biochemical markers associ-
ated with apoptosis was investigated in STR/ort knee joints
having a range of OA lesions of different severity. Sections
were immunostained for bcl-2, bax, caspase-3, caspase-8
and caspase-9. Bcl-2 is an anti-apoptotic member of the
Fig. 2. Correlation between the number of apoptotic chondrocytes in STR/ort medial tibial cartilage adjacent to OA lesions and the grade of
the lesion.
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bcl-2 family of proteins and dimerizes with apoptotic mem-
bers, for example bax, to neutralise their actions. The levels
of bcl-2 immunostaining of chondrocytes varied with age
and disease progression (Fig. 5). Young pre-lesional STR/
ort mice (6 weeks) showed prominent bcl-2 immuno-
staining of both the medial and lateral tibial plateaux
chondrocytes (Fig. 5A, B). The medial and lateral tibial
cartilage chondrocytes of young CBA control mice showed
a very similar level and pattern of bcl-2 staining (Fig. 6 A, B).
Control sections showed no staining of chondrocytes (not
shown).
With increase of age to 11–12 weeks, there was a
decrease in bcl-2 immunostaining throughout the medial
and lateral tibial cartilage in both strains (Fig. 5C–F, Fig.
6C–D). The decrease tended to be more marked in the
STR/ort mice, but this appeared to be strain-related rather
than lesion-related since reduced staining occurred on the
unaffected lateral plateau (Fig. 5D) as well as on the medial
plateau (Fig. 5C) where early lesions developed. Moreover,
chondrocytes in the areas of morphologically normal
medial tibial plateau cartilage distant from a lesion (Fig.
5E), also exhibited generally lower levels of bcl-2 staining
than were found in age-matched CBA control sections
(Fig. 6C).
In the STR/ort mouse, with the progression of lesions to
a more advanced stage, there is very marked loss of bcl-2
staining in the chondrocytes immediately adjacent to the
lesion (Fig. 5G). However, chondrocytes in the correspond-
ing non-lesional lateral cartilage continue to exhibit low
levels of staining throughout the cartilage (Fig. 5H), as do
chondrocytes in non-lesional cartilage elsewhere (Fig. 5I,
J) and in age-matched control CBA mice (Fig. 6E, F). This
pattern of bcl-2 staining was observed in lesional and
non-lesional cartilage in mice up to the age of 40 weeks
(data not shown).
Bax is a pro-apoptotic member of the bcl-2 family of
proteins. An increase in bax level in response to cellular
stress activates the mitochondrial pathway of apoptosis
and leads to cell death. We found no evidence of increasing
levels of bax in STR/ort murine chondrocytes. Both young
STR/ort and CBA mouse (5–6 weeks) tibial chondrocytes
showed strong immunostaining for bax (Fig. 7 A, B; Fig. 8
A, B, respectively), whilst control sections showed no
staining of chondrocytes (not shown). Bax immunostaining
showed some reduction with increasing age in CBA mice
(Fig. 8C–F). In contrast, there was a more marked reduc-
tion in staining in the medial plateau chondrocytes in the
region of early lesions (grade 1–2) in 11-week STR/ort mice
(Fig. 7C). The corresponding lateral plateau (Fig. 7D)
stained similarly to age-matched CBA cartilage (Fig. 8D).
Regions of the medial cartilage distant from the lesion
recovered bax staining to a level similar to non-lesional
lateral cartilage (data not shown). Similarly medial cartilage
chondrocytes in proximity to more advanced OA lesions in
older STR/ort mice showed a similar loss of bax staining,
whilst those on the non-lesional lateral plateau stained with
the antibody (Fig. 7E, F). Preincubation of the antibody with
the bax immunising peptide abolished staining (data not
shown). Thus the immunostaining results are specific for
bax and overall, they demonstrate a loss of bax expression
Fig. 3. Toluidine blue staining of thin sections from morphologically normal and osteoarthritic STR/ort mouse medial tibial cartilage.
Morphologically-normal cartilage (A) stained intensely and exhibited a smooth surface. The underlying bone shows characteristic invasion
by bone marrow pools. Osteoarthritic cartilage (B) stains less intensely and shows extensive erosion. The underlying bone is highly sclerotic.
ac, Articular cartilage; m, marrow pools. Original magnification, ×25.
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in chondrocytes close to OA lesions in STR/ort mice rather
than any increase in the level of this protein.
Capase-8 is a key enzyme in the receptor-mediated
pathway of apoptosis. An anti-caspase-8 antibody did not
detect any immunostaining for the protein in the tibial
chondrocytes of either young or old STR/ort or CBA mice
(data not shown). However, older mice exhibited caspase-8
immunostaining in some of the trabecular bone cells of the
tibia and femur. This was abolished by incubation of the
primary antibody with a blocking peptide (data not shown).
Older CBA mice showed similar staining but of a lesser
intensity (data not shown). Young mice of either strain had
no caspase-8 staining associated with the bone.
Caspase-9 is a key enzyme of the mitochondrial-
mediated pathway of apoptosis and caspase-3 forms a
convergence point, being activated by both the receptor-
mediated and the mitochondrial-mediated pathways. How-
ever, when knee joint sections from young and old STR/ort
mice, with cartilage of both normal appearance and OA
lesions, were immunostained for these caspases, but
positive signal was detected (data not shown).
Discussion
Apoptosis, or programed cell death as it is sometimes
referred to, is an important event in development and in
maintenance of cell number and clearance of cells harbour-
ing mutations in developed tissues23. It also occurs at an
increased level in several diseases such as Alzheimer’s
disease7, Parkinson’s disease8 and cardiomyopathies24.
Increased numbers of apoptotic chondrocytes in human
osteoarthritic cartilage were first reported by Blanco et al.9
and Hashimoto et al.25 , a finding subsequently confirmed
Fig. 4. Electron microscopy of chondrocytes in STR/ort mouse medial tibial articular cartilage. A, Normal chondrocyte in non-lesional area
of the cartilage, c=cytoplasm; cm=cell membrane; lr=lacunar rim; cp=cytoplasmic process (×7500). B, Grossly fragmented chondrocyte
located adjacent to a grade 5 osteoarthritic lesion (×7500). C, Small intact chondrocyte in a lesional area with disorganised chromatin,
blebbing and numerous membrane-bound cell remnants (*) in the lacuna space (LS) (×2950). D, Shrunken chondrocyte associated with the
same lesion as that in C (×2500). The area in the box is shown in higher magnification (×7500) in frame E. Budding of cell remnants from
the cell membrane is seen. n=nucleus; c=cytoplasm.
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by others26,27. Approximately 20–50% of the chondrocytes
were found to be apoptotic in human osteoarthritic
cartilage, whilst very few such cells were detected in
normal cartilage. However, not all investigators agree that
apoptosis is a widespread phenomenon in human osteo-
arthritis28.
Most investigators of apoptosis in tissues rely on the
TUNEL technique to detect DNA strand breaks. A charac-
teristic feature of apoptosis is cleavage of DNA to produce
a series of fragments of varying size. In the TUNEL assay
these can be detected by labeling them with fluorescently
tagged dUTP. Whilst this is generally accepted as a reliable
test for apoptotic cells, it is also possible that the technique
labels DNA fragments generated in the early stages of cell
death by necrosis. Thus additional evidence of apoptosis
from alternative experimental approaches increases confi-
dence that positive results in the TUNEL assay are due to
the presence of apoptotic cells in a tissue. In the current
experiments on STR/ort mice, ultrastructural studies re-
vealed that chondrocytes in lesional areas of the tibial
cartilage have a number of morphological changes which
are characteristic of cells undergoing apoptosis. These
include changes in the appearance of nuclear chromatin,
cell membrane blebbing and the formation of membrane-
bound cell remnants or apoptotic bodies. Thus we conclude
that the TUNEL-positive chondrocytes in STR/ort cartilage
do represent cells which are undergoing, or have under-
gone, cell death by apoptosis. As discussed below, the
mechanism by which cell death occurs in the STR/ort
chondrocytes remains to be established.
Fig. 5. Immunohistochemical staining of bcl-2 protein in STR/ort mouse tibial cartilage during progression of OA. Young (6-week) pre-lesional
STR/ort mice show high levels of immunostaining for bcl-2 in both the medial (A, ×31) and lateral tibial plateau (B, ×36). By 11–12 weeks
of age, immunostaining is much reduced in the medial (C, ×36) and lateral (D, ×36) cartilage. This does not appear to be related to the low
grade lesions (grade 1 or 2) which develop at this age (C). Morphologically normal cartilage distant from the lesion also shows low levels of
immunostaining for bcl-2 (E, medial, ×33; F, lateral, ×33). At later ages when more advanced lesions develop in the medial cartilage (G, 24
weeks, grade 3, ×40) immunostaining is lost in cells adjacent to the lesion, and is of a low level in cells more distant from it. Immunostaining
is also low in chondrocytes of the lateral cartilage (H, ×37). Staining levels in morphologically normal cartilage beyond the edge of the lesion
also remain low on the medial side (I, ×40) and in the corresponding lateral cartilage (J, ×37).
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The STR/ort mouse provides a useful small animal
model of naturally occurring osteoarthritis in the tibial
cartilage14. Initial histopathological lesions are focal. They
develop predominantly in the medial tibial cartilage any
time after the age of 8 weeks and progress from roughen-
ing of the cartilage surface to full depth fibrillations and loss
of cartilage from the bone. It is also clear from results
reported above (Fig. 3), and from our previous observa-
tions, that sclerotic changes occur in the underlying tibial
bone, coincident with the progression of cartilage lesions.
The results obtained from carrying out the TUNEL assay on
a series of STR/ort mice of differing ages and stages of
osteoarthritis indicate that there are very few apoptotic cells
in morphologically normal cartilage but that the number
increases with increasing severity of the histological lesion
present. This suggests that apoptosis is a late stage event
in murine osteoarthritis and may be a consequence of other
changes rather than an initiating factor in the disease
process.
Since 85–90% of all male STR/ort mice develop tibial
osteoarthritis, studies can be designed to investigate pre-
lesional changes in cartilage in this model. Thus changes
in cytokine expression of the tibial chondrocytes were
detected by in situ hybridisation before the development of
histopathological lesions of OA in STR/ort tibial cartilage20.
Similarly, MMP13 mRNA levels in chondrocytes, as de-
tected by in situ hybridization, increased in prelesion
cartilage18, and recently we detected higher levels of
endogenously active MMP13 in tibial cartilage extracts
from 5–6 week old STR/ort mice compared to age-matched
control CBA mice19. STR/ort mice of this age do not have
histopathological lesions of OA, so again this is a pre-
lesional difference in STR/ort tibial cartilage. In contrast,
chondrocyte apoptosis is a post-lesional and, therefore,
later event.
The distribution of apoptotic chondrocytes in the tibial
cartilage is restricted to those areas where histopathologi-
cal lesions were present. The lesions are focal except in
the late stages of the disease and cartilage a little dis-
tance from a lesion has a smooth surface and appears
morphologically normal in other respects. Chondrocytes in
the latter areas had a normal ultrastructural appearance
and there were rarely any TUNEL-positive cells present.
Kim et al.26 have drawn attention to similar findings in
human osteoarthritis where the percentage of TUNEL
positive chondrocytes is higher in lesional areas than in
non-lesional cartilage in the same patient. However, the
relatively focused distribution of apoptotic cells in osteo-
arthritic cartilage does not detract from their likely impact
on tissue physiology. Such cells are unlikely to be able to
contribute to cartilage matrix repair and probably cease to
generate the proteolytic enzymes responsible for matrix
breakdown. Although early stages of osteoarthritis in
STR/ort mice are associated with increased mRNA levels
for several matrix metalloproteinases (MMPs 2, 3, 7, 8,
13) in the tibial chondrocytes, cells close to more ad-
vanced lesions show very low or no expression of these
enzymes18. These cells also show no expression of
aggrecan mRNA21. Apoptosis is an obvious reason for
the decreased transcriptional activity of these cells.
Colwell et al.29 have stressed that reduced cell viability
through apoptosis following mechanical injury of cartilage
has serious implications for subsequent repair of the
tissue. They suggested that new therapeutic approaches
Fig. 6. Immunohistochemical staining of bcl-2 protein in CBA mouse tibial cartilage chondrocytes at different ages. Young 6-week-old CBA
mice show similar levels of bcl-2 immunostaining in both the medial and lateral tibial cartilage plateaux (A, B, ×42, ×38). This decreases by
12 weeks of age (C, D, ×40, ×36). A further decrease is seen by 24 weeks (E, F) (×40). In all cases, the reduction observed was similar on
both medial (A, C, E) and lateral (B, D, F) tibial plateaux.
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should be considered to prevent such apoptosis. Whilst
this may be feasible following injury at a known time, it
is more difficult to see how this could be implemented
for non-traumatic osteoarthritis where histopathological
lesions with associated apoptotic cells may be well
advanced before diagnosis.
The stimulus for triggering apoptosis in chondrocytes is
not yet clear. There are two well-defined pathways which
Fig. 7. Immunohistochemical staining of bax protein in STR/ort mouse tibial cartilage chondrocytes during progression of OA. Prominent bax
immunostaining is present in both the medial (A, ×37) and lateral (B, ×40) plateaux of 5-week-old STR/ort mice. There is a significant
reduction in staining on the medial side with the development of grade 1–2 lesions (C) (11 weeks, ×39). Staining on the lateral plateau is only
slightly reduced (D) (×39). Progression of the disease in older mice (15 weeks, grade 2/3) is also associated with a loss of staining in cells
immediately adjacent to the OA lesion on the medial tibial plateau (E, ×33). Staining on the corresponding lateral plateau is unaffected
(F, ×35).
Fig. 8. Immunohistochemical staining of bax protein in CBA mouse tibial cartilage chondrocytes at different ages. 5-week-old CBA mice show
strong immunostaining for bax protein in both medial (A, ×38) and lateral (B, ×40) tibial plateaux. Bax staining levels decrease slightly in both
plateaux by 12 weeks of age (C, D, ×38, ×44). This pattern of staining is maintained in older animals (21 weeks) (E, F, ×33, ×36).
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signal cells to undergo apoptosis – the intracellular path-
way involving the release of cytochrome c from mitochon-
dria and the receptor-mediated pathway triggered by
activation of ‘death receptors’ such as TNF-R or Fas
(CD95). Both of these are expressed by chondro-
cytes3,30–32. Fas activation triggers apoptosis in human
chondrocytes in vitro33. When osteoarthritis was induced in
rabbits by transection of the anterior cruciate ligament in
the knee, the medial femoral and tibial cartilages produced
high levels of nitric oxide and it was proposed that this was
responsible for inducing increased levels of chondrocyte
apoptosis34. However, a recent study on human osteo-
arthritic cartilage found no greater prevalence of nitric oxide
in apoptotic chondrocytes than in non-apoptotic cells and
concluded that NO is not an initiating signal for apoptosis
in vivo35.
We investigated, using immunohistochemistry, several
biochemical markers associated with the intracellular sig-
nalling pathway triggering apoptosis (bcl-2, bax and
caspase-9) and caspase-8 which is activated by the death
receptor pathway. We also probed immunohistochemically
for caspase-3, a downstream caspase which is activated by
both pathways. Although both bcl-2 and bax were readily
detected in the chondrocytes of murine tibial cartilages, no
changes were found indicating activation of the intracellular
activation pathway of apoptosis. Classically this would
involve a change in the ratio of the two proteins such as
would occur if either bcl-2 levels decreased markedly or bax
levels increased markedly. In fact the levels of both proteins
decreased with increasing age. Moreover, the pattern and
intensity of immunostaining of both proteins in STR/ort
cartilage were similar to those in age-matched control CBA
mice, except in lesional areas where expression of both
proteins was lost in the STR/ort mouse. These findings
provide no evidence for activation of the intracellular
signalling pathway of apoptosis in STR/ort chondrocytes.
However, it is important to remember that, at best, immuno-
histochemistry is only a semiquantitative technique and in
the absence of marked changes in bel-2 relative to bax, no
conclusion as to activation of this pathway is justified.
Neither caspase-9 nor caspase-3 was detected in the
joint tissues of either strain. This may have been due to a
failure of the antibodies recognise murine antigens, or to
the transient expression of these caspases. The antibody
to caspase-8 detected antigen in murine bone cells but not
in tibial chondrocytes of either mouse strain. Again this
could be due to the transient expression of this caspase.
There is increasing evidence that mechanical injury to
cartilage triggers chondrocyte apoptosis both in vivo29,36
and in vitro37,38. The osteoarthritis of the STR/ort medial
tibial plateau is a naturally occurring disease and although
it has been proposed that there may be abnormal mechan-
ical load on the knee joint through patella subluxation in
some mice39 many mice have OA without any change in
the patella14. Nevertheless, it is clear that STR/ort cartilage
matrix proteoglycans are removed by MMP and aggreca-
nase activity16 and cleavage of matrix collagen can be
detected as soon as the histopathological lesions are
present17. Thus the mechanical properties of the matrix for
accommodating load must be compromised because of
these changes. Hence even normal loading may be suf-
ficient to mechanically injure the chondrocytes in a matrix-
depleted cartilage and initiate changes which lead to
apoptosis of the cells. The percentage of apoptotic
chondrocytes in human cartilage correlated with the level of
glycosaminoglycan release into the culture medium when
subject to mechanical stress in vitro37.
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